441 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35046382 | STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation. | 2022 Jan 19 | 1 |
2 | 35149852 | Hepatic NCoR1 deletion exacerbates alcohol-induced liver injury in mice by promoting CCL2-mediated monocyte-derived macrophage infiltration. | 2022 Feb 11 | 1 |
3 | 35150895 | Enterocyte-specific ATGL overexpression affects intestinal and systemic cholesterol homeostasis. | 2022 Apr | 1 |
4 | 35183812 | Chronic exposure to low-dose cadmium facilitated nonalcoholic steatohepatitis in mice by suppressing fatty acid desaturation. | 2022 Mar 15 | 1 |
5 | 35203398 | Basal Autophagy Is Necessary for A Pharmacologic PPARα Transactivation. | 2022 Feb 21 | 2 |
6 | 35224041 | Downregulation of PTEN Promotes Autophagy via Concurrent Reduction in Apoptosis in Cardiac Hypertrophy in PPAR α-/- Mice. | 2022 | 2 |
7 | 35419389 | Hepatic PPARα Is Destabilized by SIRT1 Deacetylase in Undernourished Male Mice. | 2022 | 2 |
8 | 35428314 | L-theanine prevents progression of nonalcoholic hepatic steatosis by regulating hepatocyte lipid metabolic pathways via the CaMKKβ-AMPK signaling pathway. | 2022 Apr 15 | 2 |
9 | 35460276 | Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis. | 2022 Apr 23 | 5 |
10 | 35526488 | PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice. | 2022 Jul 12 | 2 |
11 | 35533983 | Transcriptional Integration of Distinct Microbial and Nutritional Signals by the Small Intestinal Epithelium. | 2022 May 6 | 1 |
12 | 35538760 | [Mechanism of Triclosan in the Treatment of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology]. | 2022 Apr | 1 |
13 | 33093014 | ETV5 Regulates Hepatic Fatty Acid Metabolism Through PPAR Signaling Pathway. | 2021 Jan | 1 |
14 | 33184849 | Co-option of PPARα in the regulation of lipogenesis and fatty acid oxidation in CLA-induced hepatic steatosis. | 2021 Jun | 1 |
15 | 33257471 | Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance. | 2021 Nov | 2 |
16 | 33352397 | IL-8 exacerbates alcohol-induced fatty liver disease via the Akt/HIF-1α pathway in human IL-8-expressing mice. | 2021 Feb | 2 |
17 | 33417961 | Icaritin ameliorates hepatic steatosis via promoting fatty acid β-oxidation and insulin sensitivity. | 2021 Mar 1 | 1 |
18 | 33491665 | Discordant hepatic fatty acid oxidation and triglyceride hydrolysis leads to liver disease. | 2021 Jan 25 | 1 |
19 | 33500723 | Activation of N-methyl-D-aspartate receptor regulates insulin sensitivity and lipid metabolism. | 2021 | 1 |
20 | 33758172 | Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver. | 2021 Mar 23 | 4 |
21 | 33785868 | Ahnak deficiency attenuates high-fat diet-induced fatty liver in mice through FGF21 induction. | 2021 Mar | 1 |
22 | 33798787 | Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver. | 2021 | 2 |
23 | 33892114 | PPARα agonist WY-14,643 enhances ethanol metabolism in mice: Role of catalase. | 2021 Jun | 2 |
24 | 33916086 | Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice. | 2021 Apr 1 | 1 |
25 | 33934381 | Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk. | 2021 Oct | 2 |
26 | 34052195 | Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, blocks steatosis and alters the inflammatory response in a mouse model of inflammation-dioxin interaction. | 2021 Aug 25 | 2 |
27 | 34092291 | Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α. | 2021 Jun | 1 |
28 | 34116071 | Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo. | 2021 Sep 1 | 1 |
29 | 34192547 | FGF21 promotes thermogenic gene expression as an autocrine factor in adipocytes. | 2021 Jun 29 | 1 |
30 | 34207854 | Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism. | 2021 Jun 9 | 1 |
31 | 34244236 | PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy. | 2021 Sep 1 | 1 |
32 | 34267188 | Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway. | 2021 Jul 15 | 2 |
33 | 34268878 | Pectic Oligogalacturonide Facilitates the Synthesis and Activation of Adiponectin to Improve Hepatic Lipid Oxidation. | 2021 Oct | 1 |
34 | 34281337 | γ-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis via the LKB1-AMPK-mTOR Pathway. | 2021 Jul 28 | 1 |
35 | 34288722 | Hepatic ADTRP overexpression does not influence lipid and glucose metabolism. | 2021 Oct 1 | 1 |
36 | 34347073 | 3' untranslated region of Ckip-1 inhibits cardiac hypertrophy independently of its cognate protein. | 2021 Sep 21 | 1 |
37 | 34380027 | GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK. | 2021 Aug 10 | 1 |
38 | 34380288 | Comprehensive multi-omics approaches reveal the hepatotoxic mechanism of perfluorohexanoic acid (PFHxA) in mice. | 2021 Oct 10 | 2 |
39 | 34415766 | Novel ι-Carrageenan Tetrasaccharide Alleviates Liver Lipid Accumulation via the Bile Acid-FXR-SHP/PXR Pathway to Regulate Cholesterol Conversion and Fatty Acid Metabolism in Insulin-Resistant Mice. | 2021 Sep 1 | 4 |
40 | 34422410 | ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway. | 2021 | 1 |
41 | 34454927 | β-elemene blocks lipid-induced inflammatory pathways via PPARβ activation in heart failure. | 2021 Nov 5 | 1 |
42 | 34474167 | PAQR9 regulates hepatic ketogenesis and fatty acid oxidation during fasting by modulating protein stability of PPARα. | 2021 Nov | 1 |
43 | 34615341 | Critical role of peroxisome proliferator-activated receptor α in promoting platelet hyperreactivity and thrombosis under hyperlipidemia. | 2021 Oct 7 | 1 |
44 | 34986301 | The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE-/-FXR-/- Mice. | 2021 Dec | 1 |
45 | 35087411 | Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways. | 2021 | 1 |
46 | 31785270 | Sleep profile during fasting in PPAR-alpha knockout mice. | 2020 Feb 1 | 1 |
47 | 31914699 | Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet-induced obese mice. | 2020 Jan | 1 |
48 | 32070771 | Effects of clofibrate and KH176 on life span and motor function in mitochondrial complex I-deficient mice. | 2020 Jun 1 | 2 |
49 | 32145476 | Ambient fine particulate matter disrupts hepatic circadian oscillation and lipid metabolism in a mouse model. | 2020 Jul | 2 |
50 | 32192216 | PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice. | 2020 Mar 17 | 1 |